Summit Therapeutics SMMT Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Summit Therapeutics’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's operating lease liabilities (total)?
- Summit Therapeutics (SMMT) reported operating lease liabilities (total) of $20.89M in Q4 2025.
- How has Summit Therapeutics's operating lease liabilities (total) changed year-over-year?
- Summit Therapeutics's operating lease liabilities (total) increased by 189.4% year-over-year, from $7.22M to $20.89M.
- What is the long-term trend for Summit Therapeutics's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Summit Therapeutics's operating lease liabilities (total) has grown at a 114.0% compound annual growth rate (CAGR), from $465K to $20.89M.
- What does operating lease liabilities (total) mean?
- The total present value of future payments owed for leased assets like offices or equipment.
- How do you interpret operating lease liabilities (total)?
- An increase indicates expansion of physical footprint or longer lease terms, while a decrease suggests downsizing or the expiration of lease contracts.
- How does operating lease liabilities (total) compare across companies?
- Depends heavily on the company's real estate strategy and whether they lease or own their R&D facilities.